NDRG1 and breast carcinoma: Overall, the results demonstrated that mitochondrially targeted iron chelators mitoDFX and mitoDFO are capable of inducing NDRG1 mRNA and protein levels in breast cancer cells, while only low levels were induced in non-malignant cells.